CA
NZ
UK
AU
IND
US
Key HighlightsAstraZeneca (NYSE:AZN) reported third quarterRevenueof USD 16.209 billion, up 7 percent, with core EPS of USD 2.79, up 17 percent, and reconfirmed full-year guidance of mid-to-high single digit revenue growth.Sanofi (NASDAQ:SNY) reported third quarter sales of 14.444 billion euro, up 14.3 percent at …
● No company-specific news was found.
● Pacira is best known for Exparel, a long-acting non-opioid pain medication.
● The company raised its 2026 outlook.
Key Highlights● Enovis slid on Friday, October 30, 2026, in closing data.● No company-specific news was found.● No catalyst was cited.● Enovis is an orthopedics-focused medical technology company.Enovis (NYSE:ENOV) slid on Friday, October 30, 2026, according to closing data compiled by market data. No …
● Regeneron was the S&P 500's top gainer.
● No company-specific catalyst could be confirmed.
● The application covers sickle cell disease.
● Higher medical costs forced a cut to 2026 profit forecasts.
● It cut itsRevenueoutlook on lowerBiologicsattachment.
Please wait processing your request...